China’s Infant Formula Market Loses Allure for Reckitt Benckiser

, , Comments Off on China’s Infant Formula Market Loses Allure for Reckitt Benckiser

The promise of surging baby-formula sales in China fueled Reckitt Benckiser Group Plc’s $18 billion acquisition of Enfamil maker Mead Johnson. Only four years later, the U.K. company is considering …
( read original story …)